Immuno-genomics: rare diseases; immunodeficiencies; inborn errors of immunity; clonal hematopoiesis
https://shorturl.at/MxQ7O
https://www.immuno-genomics.com
Lisenka Vissers (Radboudumc, NL) will speak on translating long-read genome sequencing into clinical applications for rare diseases.
Free via Zoom – registration required.
wma.eventsair.com/eshg-webinar...
Lisenka Vissers (Radboudumc, NL) will speak on translating long-read genome sequencing into clinical applications for rare diseases.
Free via Zoom – registration required.
wma.eventsair.com/eshg-webinar...
BNR Beter aflevering: lnkd.in/eetSKFBd
Ook op Spotify: lnkd.in/eVC-Fzxt
BNR Beter aflevering: lnkd.in/eetSKFBd
Ook op Spotify: lnkd.in/eVC-Fzxt
So satisfying to see a long journey end in best-possible diagnostic test for patients with rare diseases @radboudumc.bsky.social.
www.radboudumc.nl/en/news-item...
(1/n)
So satisfying to see a long journey end in best-possible diagnostic test for patients with rare diseases @radboudumc.bsky.social.
www.radboudumc.nl/en/news-item...
(1/n)
Exciting to show clinical utility of lrGS in multi-center study.
👉 bit.ly/4oqMWCY
Exciting to show clinical utility of lrGS in multi-center study.
👉 bit.ly/4oqMWCY
👉 bit.ly/4oqMWCY
Topics include: the impact of structural variation on the 3D genome in disease; single-cell DNA sequencing of somatic mutations; the role of transcription compartments in gene regulation; synonymous mutations and their consequences
Topics include: the impact of structural variation on the 3D genome in disease; single-cell DNA sequencing of somatic mutations; the role of transcription compartments in gene regulation; synonymous mutations and their consequences
Free to read here: rdcu.be/eu0KR
Free to read here: rdcu.be/eu0KR
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Have a fab conference all - regards to all friends and collaborators and keep the “tweets” coming!
Have a fab conference all - regards to all friends and collaborators and keep the “tweets” coming!
The SPRQ-Nx chemistry, now in beta access, delivers complete genomes for under $300 at scale.
View the press release: bit.ly/4o06eyH
The SPRQ-Nx chemistry, now in beta access, delivers complete genomes for under $300 at scale.
View the press release: bit.ly/4o06eyH
📅 The first episode is on 2nd October 13:00-14:00 CET (12:00-13:00 WAT)
Join us on teams (no pre-registration needed):
lnkd.in/ecwt-Nva
Meeting ID: 328 781 679 974 3
Passcode: F63nX7JV
📅 The first episode is on 2nd October 13:00-14:00 CET (12:00-13:00 WAT)
Join us on teams (no pre-registration needed):
lnkd.in/ecwt-Nva
Meeting ID: 328 781 679 974 3
Passcode: F63nX7JV
Cas not only presented his impressive thesis - but his outstanding offer was recognized with a “cum laude” distinction. Well done and very well deserved!
Cas not only presented his impressive thesis - but his outstanding offer was recognized with a “cum laude” distinction. Well done and very well deserved!
📺 youtu.be/JmlY5omxQVc
📄 www.nature.com/articles/s41...
📺 youtu.be/JmlY5omxQVc
📄 www.nature.com/articles/s41...
Amazing - and first glimpses of hope for patients and families with this devastating rare disease.
www.bbc.com/news/article...
Amazing - and first glimpses of hope for patients and families with this devastating rare disease.
www.bbc.com/news/article...
Genetic epilepsies and other neuronal ion channel disorders: Mechanisms and therapeutic perspectives; 23rd-25th September 2025, Tübingen, Germany”.
Here the first DNA was isolated - ever.
Genetic epilepsies and other neuronal ion channel disorders: Mechanisms and therapeutic perspectives; 23rd-25th September 2025, Tübingen, Germany”.
Here the first DNA was isolated - ever.
See you all in Pavia for #EuroDysmorpho 2026!
@eshg.bsky.social @silk93.bsky.social
See you all in Pavia for #EuroDysmorpho 2026!
@eshg.bsky.social @silk93.bsky.social
Amongst them my wonderful colleague Richarda de Voer talking about the role for postzygotic mutations in cancer.
Amongst them my wonderful colleague Richarda de Voer talking about the role for postzygotic mutations in cancer.
…I’d be disappointed if he could squeeze the big 500degree plan in less then 200 slides!
…I’d be disappointed if he could squeeze the big 500degree plan in less then 200 slides!
…the future of germline testing is clear now: generic first tier testing by long-read genome sequencing!
…the future of germline testing is clear now: generic first tier testing by long-read genome sequencing!
@nvhg.bsky.social
@nvhg.bsky.social